Biotechnology - UK, Antibiotics and Infectious diseases

Filter

Popular Filters

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

Smith & Nephew shares fall as HP802-247 living cell spray-on therapy fails to meet primary endpoint

14-10-2014

Global medical technology business Smith & Nephew has found its Phase III study of HP802-247, a living…

Antibiotics and Infectious diseasesBiotechnologyHP802-247ResearchSmith & NephewUK

Helperby Therapeutics and Cadila make progress on first antibiotic resistance breaker

Helperby Therapeutics and Cadila make progress on first antibiotic resistance breaker

19-06-2014

Helperby Therapeutics, a spin-out drug discovery company from St George’s University of London, UK,…

Antibiotic resistanceAntibioticsAntibiotics and Infectious diseasesBiotechnologyCadila PharmaceuticalsHelperby TherapeuticsIndiaUK

Argenta and Antabio meet milestone in anti-bacterial drug discovery collaboration

Argenta and Antabio meet milestone in anti-bacterial drug discovery collaboration

10-03-2014

Drug discovery company Argenta, a subsidiary of Belgian drugmaker Galapagos (Euronext: GLPG), has achieved…

Antibiotics and Infectious diseasesArgentaBiotechnologyFranceResearchUK

Back to top